were 0.06-0.5 and 0.163 mg/L, respectively. These values were not obviously different, indicating that the elevated MICs of ampicillin did not affect the SK phenotype. This suggests that reduced ampicillin susceptibility and the SK phenotype may be caused by different mechanisms. Moreover, there was not any obvious difference of growth speed among clinical isolates with the SK phenotype and those with the non-SK phenotype. These data suggest that some PRGBS clinical isolates may have emerged from the SK phenotype. Under ampicillin pressure, PSGBS isolates with the SK phenotype might survive more than those with the non-SK phenotype and some PRGBS clinical isolates might emerge from such survivors. Although the number of clinical isolates investigated in this study was limited, our findings are expected to be crucial for reducing the further emergence of PRGBS from PSGBS.
carbapenem resistance is emerging among these species and, recently, NDM-1-producing A. pittii have been reported worldwide, 2-5 becoming a public health concern. However, few cases have been reported in Europe and no case has been described in France.
Here, we report the first French case of NDM-1-producing A. pittii, in a patient with no history of travel. A man in his mid-sixties was admitted to the University Hospital of Angers, for persistent fever and headaches. A cerebral CT scan identified multiple nodular lesions, defined as likely cerebral abscesses. A cerebral biopsy was performed and bacterial cultures were positive for Nocardia beijingensis (identified by the French Observatory of Nocardia). The patient evolved favourably under a 6 week combination of ceftriaxone and trimethoprim/sulfamethoxazole. During his hospitalization, in the context of an OXA-48-producing Klebsiella pneumoniae epidemic, rectal swabs were performed for carbapenemase-producing Enterobacteriaceae screening. Two swabs, performed on days 11 and 18 after patient admission, were negative for carbapenemase-producing isolates on bacterial cultures. The third sample, performed on day 26, was positive with colonies identified as Acinetobacter calcoaceticusAcinetobacter baumannii (ACB) by MALDI-TOF MS using the VITEK V R MS IVD system (bioMérieux) and as A. pittii using the VITEK V R MS RUO mode. A. pittii identification was confirmed by partial sequencing of the rpoB gene. 1 The isolate was highly resistant to all b-lactams including carbapenems, with MICs of imipenem and meropenem .32 mg/L. Real-time PCR assays identified a bla NDM gene, characterized as a bla NDM-1 variant by sequencing.
Genomic DNA of A. pittii was sequenced using the paired-end strategy. The genome was compared with A. pittii strain ATCC 19 004 (accession no. NZ_APQP00000000). The genome of A. pittii was assembled into 207 scaffolds corresponding to a genome size of 3 920 956 bp (GC content of 38.9%). The total number of predicted coding sequences in the strain G867 genome was 3629 with 79 predicted tRNAs and 10 predicted rRNAs. A total of 3169 genes (87.3%) were assigned to putative functions and 460 genes (12.7%) were identified as having an unknown function. The A. pittii G867 genome did not contain any prophage regions or plasmids. The MLST (Pasteur) scheme (http://pubmlst.org/abaumannii/) revealed a new ST, ST838.
Antimicrobial resistance genes were retrieved by blasting sequences from the genome against the ARG-ANNOT database. 6 Eight antibiotic resistance genes were detected. A. pittii G867 harboured macA and macB genes, involved in MacAB macrolide efflux protein expression, and the aminoglycoside O-phosphotransferase gene aphA6. The b-lactamases genes bla ADC , blaA1, blaA2 and bla OXA-213 were detected. Lastly, the gene bla NDM-1 , located in the chromosome, displayed a similar organization to that of other NDM-1-producing A. pittii strains (Figure 1) . We noticed the loss of DgroES, Dpac and one IS (ISAba) in the transposon extremity. Integration of this transposon in the chromosome seems to be due to ISs (ISAba125 and InsE).
We identified here the first instance of NDM-1-producing A. pittii carriage in France. Emergence of NDM-1-producing A. pittii is reported worldwide. [2] [3] [4] [5] Here, surprisingly, the patient had no recent history of travel. However, the patient combined two pathogens most prevalent in China and rarely isolated in Europe: N. beijingensis and NDM-producing A. pittii. No contact with Asia has been identified. Nevertheless, the coincidence of these bacteria is surprising and the patient may not have identified an unknown Asiatic source in his history.
Most NDM-1-producing A. pittii have been reported in Asiatic countries. 3, 7, 8 Other cases have been noticed in South America 5 or in Turkey. 9 Only two cases have been reported in Europe. In Belgium, an NDM-1 A. pittii isolate was linked with recent travel to Egypt and north-west India. 10 In Denmark, an ST119 NDM-1-producing A. pittii has been identified in a patient with no recent history of travel. As in this last case, the description here of bla NDM-1 -carrying A. pittii in France is made in a patient with no recent history of travel. The diagnosis was made fortuitously from a rectal swab sample. The context of this diagnosis suggests that the circulation of ACB species carrying bla NDM may be underestimated in France. This case raises questions about the management of patients with carbapenemase-producing A. pittii carriage in hospitals. Here, all the patients hospitalized in the same ward and screened for carbapenemase carriage were negative. Dissemination of NDM-1-producing A. pittii has been noted in an ICU. 7 NDM-producing A. pittii had then been isolated in the air within the ICU, being suspected to contribute to the dissemination of the bacterium. Therefore, early detection of carbapenemases in Acinetobacter species seems critical to control the dissemination of carbapenemase-producing isolates.
Here, this first French case of NDM-producing A. pittii in a patient with no history of travel enhances the problem of carbapenemaseproducing ACB species and their management in hospitals.
Nucleotide sequence accession number
The sequence of the A. pittii G867 isolate has been deposited in GenBank (FKLP01000001-FKLP01000207).
